RGBP huge 8k out new CEO and On March 23,2021 Todd S. Caven ( “Caven”) entered into an agreement with Regen BioPharma, Inc. ( “Company”) whereby Caven would assist the Company in obtaining the agreement of the creditors of the Company (“Creditors” or singularly “Creditor”) to settle any and all claims against the Company upon terms acceptable to the Company (“Agreement”).

https://www.otcmarkets.com/filing/html?id=148...HNdAflQ0th